BRAF and colonic neoplasm: In cell growth tests of the two colon cancer cell lines with BRAF-V600E mutation, HT29 (MSI-low, not hypermutated) and RKO (MSI-HI)32, HT29 cells were highly sensitive to PLX4720 whereas RKO cells were rather resistant which is consistent with previous report31.